ARQ 197
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Hepatocellular Carcinoma
Conditions
Advanced Hepatocellular Carcinoma
Trial Timeline
Jul 1, 2012 → Mar 1, 2014
NCT ID
NCT01656265About ARQ 197
ARQ 197 is a phase 1 stage product being developed by Kyowa Kirin for Advanced Hepatocellular Carcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT01656265. Target conditions include Advanced Hepatocellular Carcinoma.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Hepatocellular Carcinoma were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01656265 | Phase 1 | Completed |
| NCT01580735 | Phase 2 | Completed |
| NCT01152645 | Phase 2 | Completed |
Competing Products
20 competing products in Advanced Hepatocellular Carcinoma